MindBio Therapeutics (XCNQ:MBIO) FCF Yield % : -18.46 (As of May. 14, 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, MindBio Therapeutics's Trailing 12-Month Free Cash Flow is C$-1.35 Mil, and Market Cap is C$7.32 Mil. Therefore, MindBio Therapeutics's FCF Yield % for today is -18.46%.

The historical rank and industry rank for MindBio Therapeutics's FCF Yield % or its related term are showing as below:

XCNQ:MBIO' s FCF Yield % Range Over the Past 10 Years
Min: -50.77 Med: -18.46 Max: -14.51
Current: -18.46

During the past 3 years, the highest FCF Yield % of MindBio Therapeutics was -14.51%. The lowest was -50.77%. And the median was -18.46%.

XCNQ:MBIO's FCF Yield % is ranked worse than
56.14% of 1555 companies
in the Biotechnology industry
Industry Median: -14.28 vs XCNQ:MBIO: -18.46

MindBio Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -66.67%.

MindBio Therapeutics FCF Yield % Historical Data

The historical data trend for MindBio Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics FCF Yield % Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

FCF Yield %

-21.16

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial				-	-	-23.36	-21.58	-14.19

Competitive Comparison of MindBio Therapeutics's FCF Yield %

For the Biotechnology subindustry, MindBio Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's FCF Yield % falls into.

MindBio Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

MindBio Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-1.971	/	9.31329
	=	-21.16%

MindBio Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.118	*	4	/	3.326175
	=	-14.19%

MindBio Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

MindBio Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.